Chargement en cours...
Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?
Over the last 30 years, studies of aberrant DNA methylation in hematologic malignancies have been dominated by the primary focus of understanding promoter hypermethylation. These efforts not only resulted in a better understanding of the basis of epigenetic silencing of tumor suppressor genes but al...
Enregistré dans:
| Publié dans: | Front Oncol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4980682/ https://ncbi.nlm.nih.gov/pubmed/27563627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2016.00182 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|